MedPath

Antithrombin III human

Generic Name
Antithrombin III human
Brand Names
Thrombate III
Drug Type
Biotech
CAS Number
9000-94-6
Unique Ingredient Identifier
T0LTO7L82X

Overview

A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.

Indication

Antithrombin III human is a human antithrombin (AT) indicated in patients with hereditary antithrombin deficiency for the treatment and prevention of thromboembolism and prevention of peri-operative and peri-partum thromboembolism

Associated Conditions

  • Hereditary antithrombin III deficiency

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2021/06/08
Phase 3
Recruiting
2021/06/03
N/A
Completed
2021/05/24
Phase 2
Terminated
Enrique Ginzburg
2020/12/03
N/A
Completed
2019/08/13
Phase 1
Withdrawn
2015/12/16
Phase 1
Completed
2014/10/30
Phase 4
Withdrawn
Vastra Gotaland Region
2012/10/03
Phase 1
Terminated
2012/02/10
Phase 3
Completed
2010/09/14
Phase 4
UNKNOWN
University of Bari

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
ANTITHROMBIN III IMMUNO
02237812
Powder For Solution - Intravenous
1650 UNIT / KIT
7/5/1999
ANTITHROMBIN III NF
takeda canada inc
02237810
Powder For Solution ,  Kit - Intravenous
1100 UNIT / VIAL
7/5/1999
ANTITHROMBIN III NF
takeda canada inc
02237811
Powder For Solution ,  Kit - Intravenous
550 UNIT / VIAL
7/5/1999
THROMBATE III
02189135
Powder For Solution - Intravenous
500 UNIT / VIAL
N/A
THROMBATE III PWS IV 1000IU/VIAL
miles inc. - pharmaceutical division
02020572
Powder For Solution - Intravenous
1000 UNIT / VIAL
12/31/1995
THROMBATE III PWS IV 500IU/VIAL
miles inc. - pharmaceutical division
02020580
Powder For Solution - Intravenous
500 UNIT / VIAL
12/31/1995
THROMBATE III
02189143
Powder For Solution - Intravenous
1000 UNIT / VIAL
11/11/1996

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
ANBINEX POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION
59259
POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN
Uso Hospitalario
Commercialized
ATRYN 1.750 UI POLVO PARA SOLUCION PARA PERFUSION
Gtc Biotherapeutics Uk Limited
06355002
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Uso Hospitalario
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.